Triple

T2897294
Position Surface form Disambiguated ID Type / Status
Subject HIV Vaccine Trials Network E63970 entity
Predicate uses P98 FINISHED
Object Good Clinical Practice guidelines E131969 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Good Clinical Practice guidelines | Statement: [HIV Vaccine Trials Network, uses, Good Clinical Practice guidelines]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Good Clinical Practice guidelines
Context triple: [HIV Vaccine Trials Network, uses, Good Clinical Practice guidelines]
  • A. ICH E6 Good Clinical Practice chosen
    ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
  • B. GAC Principles and Guidelines
    GAC Principles and Guidelines are a set of policy frameworks and best-practice recommendations developed to guide governments’ participation and advice on public policy issues related to the global Domain Name System within ICANN.
  • C. ICH Q8 Pharmaceutical Development
    ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
  • D. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • E. ICH Q9 Quality Risk Management
    ICH Q9 Quality Risk Management is an international guideline that provides a systematic, science- and risk-based approach to identifying, evaluating, and controlling quality risks throughout the lifecycle of pharmaceutical products.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ab4c45822c8190830c5f2bb97bcfd0 completed March 6, 2026, 9:51 p.m.
NER Named-entity recognition batch_69abe08e7b248190a6bb0f6999f99c23 completed March 7, 2026, 8:23 a.m.
NED1 Entity disambiguation (via context triple) batch_69b03188d84081909e23b46c2f75250b completed March 10, 2026, 2:58 p.m.
Created at: March 6, 2026, 10:08 p.m.